SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554757-13-000319
Filing Date
2013-05-15
Accepted
2013-05-15 17:28:35
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 form10k.htm 10-K 1964517
2 GRAPHIC logo.jpg GRAPHIC 31470
3 CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002 ex31-1.htm EX-31.1 14138
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex32-1.htm EX-32.1 4652
  Complete submission text file 0001554757-13-000319.txt   4553425

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE tpiv-20121231.xml EX-101.INS 463187
6 XBRL SCHEMA FILE tpiv-20121231.xsd EX-101.SCH 44691
7 XBRL CALCULATION FILE tpiv-20121231_cal.xml EX-101.CAL 18204
8 XBRL DEFINITION FILE tpiv-20121231_def.xml EX-101.DEF 68793
9 XBRL LABEL FILE tpiv-20121231_lab.xml EX-101.LAB 202918
10 XBRL PRESENTATION FILE tpiv-20121231_pre.xml EX-101.PRE 127211
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27239 | Film No.: 13848717
SIC: 2834 Pharmaceutical Preparations